Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Daylight-mediated Photodynamic Therapy of Actinic Keratoses: a Randomized, Double-blinded Pilot Study Comparing Topical 0.2% Hexylaminolaevulinate With 16% Methylaminolaevulinate

NCT02149342 is registered in ClinicalTrials.gov with Joint Authority for Päijät-Häme Social and Health Care as lead sponsor.

NCT NCT02149342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02149342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Daylight-mediated Photodynamic Therapy of Actinic Keratoses: a Randomized, Double-blinded Pilot Study Comparing Topical 0.2% Hexylaminolaevulinate With 16% Methylaminolaevulinate
Lead sponsor
Joint Authority for Päijät-Häme Social and Health Care
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2014
Completion date
September 30, 2015
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratoses